Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...

A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes.

GLP-1 receptor agonists may aid smoking cessation by curbing cravings and mitigating weight gain, which often are impediments ...

Regeneron Pharmaceuticals has announced that it will be gaining rights to Hansoh Pharmaceuticals’ investigational dual ...

Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

According to leaders in obesity and nutrition research, following these key nutrition guidelines will make the most of GLP-1 ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced stages of clinical development in China Phase 2 data suggest potentially similar ...